Characterization of alternate encounter assemblies of SARS-CoV-2 main protease

Annie Aniana, Nashaat T. Nashed, Rodolfo Ghirlando, Victoria N. Drago, Andrey Kovalevsky, John M. Louis

Research output: Contribution to journalArticlepeer-review

Abstract

The assembly of two monomeric constructs spanning segments 1-199 (MPro1-199) and 10-306 (MPro10-306) of SARS-CoV-2 main protease (MPro) was examined to assess the existence of a transient heterodimer intermediate in the N-terminal autoprocessing pathway of MPro model precursor. Together, they form a heterodimer population accompanied by a 13-fold increase in catalytic activity. Addition of inhibitor GC373 to the proteins increases the activity further by ∼7-fold with a 1:1 complex and higher order assemblies approaching 1:2 and 2:2 molecules of MPro1-199 and MPro10-306 detectable by analytical ultracentrifugation and native mass estimation by light scattering. Assemblies larger than a heterodimer (1:1) are discussed in terms of alternate pathways of domain III association, either through switching the location of helix 201 to 214 onto a second helical domain of MPro10-306 and vice versa or direct interdomain III contacts like that of the native dimer, based on known structures and AlphaFold 3 prediction, respectively. At a constant concentration of MPro1-199 with molar excess of GC373, the rate of substrate hydrolysis displays first order dependency on the MPro10-306 concentration and vice versa. An equimolar composition of the two proteins with excess GC373 exhibits half-maximal activity at ∼6 μM MPro1-199. Catalytic activity arises primarily from MPro1-199 and is dependent on the interface interactions involving the N-finger residues 1 to 9 of MPro1-199 and E290 of MPro10-306. Importantly, our results confirm that a single N-finger region with its associated intersubunit contacts is sufficient to form a heterodimeric MPro intermediate with enhanced catalytic activity.

Original languageEnglish
Article number107675
JournalJournal of Biological Chemistry
Volume300
Issue number9
DOIs
StatePublished - Sep 2024

Funding

This work was supported by the Intramural Research Program of National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH and the Office of Biological and Environmental Research supported research at ORNL's Center for Structural Molecular Biology (CSMB), a DOE Office of Science User Facility. ORNL is managed by UT-Battelle LLC for DOE\u2019s Office of Science. This work was supported by the Intramural Research Program of National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH and the Office of Biological and Environmental Research supported research at ORNL's Center for Structural Molecular Biology (CSMB), a DOE Office of Science User Facility. ORNL is managed by UT-Battelle LLC for DOE's Office of Science. A. A. N. T. N. R. G. V. N. D. A. K. and J. M. L. methodology; A. A. N. T. N. R. G. V. N. D. A. K. and J. M. L. investigation; A. A. N. T. N. R. G. V. N. D. A. K. and J. M. L. writing\u2013review and editing; N. T. N. A. K. and J. M. L. writing\u2013original draft; A. K. and J. M. L. conceptualization; J. M. L. funding acquisition. Funding Source: NIDDK; Project number: DK075166-01 (J. M. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

FundersFunder number
National Institute of Diabetes and Digestive and Kidney Diseases
Biological and Environmental Research
Oak Ridge National Laboratory
National Institutes of Health
Canadian Society for Molecular Biosciences
ORNL's Center for Structural Molecular Biology
UT-Battelle
Office of ScienceDK075166-01

    Keywords

    • alternate folding pathways
    • dimer interface
    • fold-switching
    • inhibitor binding
    • monomer-dimer equilibrium
    • precursor processing
    • protein folding
    • protein fragment assembly
    • SARS-CoV-2 main protease
    • structure comparison
    • swapped dimer

    Fingerprint

    Dive into the research topics of 'Characterization of alternate encounter assemblies of SARS-CoV-2 main protease'. Together they form a unique fingerprint.

    Cite this